Literature DB >> 12021194

Activation of erythropoietin receptor through a novel extracellular binding site.

Tatjana Naranda1, R Ilene Kaufman, Jin Li, Kenneth Wong, Annegret Boge, Dan Hallén, Kim Y C Fung, Mark W Duncan, Niels Andersen, Avram Goldstein, Lennart Olsson.   

Abstract

Activation of erythropoietin (EPO) receptor (EPOR) by a small peptide (ERP) was reported previously. ERP binds to a different receptor site than EPO, and binding of ERP does not change the dissociation constant and maximal binding for EPO binding to the receptor. The extracellular binding site for ERP is now characterized. The site is located in the membrane proximal, extracellular part of the receptor. ERP binds to a region on the EPOR that contains the same sequence as ERP. It is speculated that ERP binds to its identical sequence on EPOR, as ERP self-interacts. ERP is specific for EPOR and associates noncovalently with EPOR in a ratio 1:1. Peptide binding to the receptor results in receptor-mediated cellular proliferation, intracellular signaling, and erythroid colony-forming unit formation in bone marrow cells. The activity is comparable to that of EPO. Recognition of such receptor sites represents a new and important concept in receptor function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021194     DOI: 10.1210/endo.143.6.8860

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Angiogenesis, neurogenesis and brain recovery of function following injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Curr Opin Investig Drugs       Date:  2010-03

2.  Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor.

Authors:  James L Miller; Timothy J Church; Dmitri Leonoudakis; Karen Lariosa-Willingham; Normand L Frigon; Connie S Tettenborn; Jeffrey R Spencer; Juha Punnonen
Journal:  Mol Pharmacol       Date:  2015-05-27       Impact factor: 4.436

3.  Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.

Authors:  Ye Xiong; Asim Mahmood; Changsheng Qu; Humaira Kazmi; Zheng Gang Zhang; Constance T Noguchi; Timothy Schallert; Michael Chopp
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

Review 4.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

Review 5.  The Effect of Recombinant Human Erythropoietin on Bacterial Growth: A Dual-Edged Sword.

Authors:  Ankur Mittal; Vandana Singh; Sheemona Chowdhary; Amal Moideen; Deepak Kumar; Kunal Maniar; Rajasri Bhattacharyya; Dibyajyoti Banerjee
Journal:  Kidney Dis (Basel)       Date:  2018-11-13

6.  Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT.

Authors:  Mostafa A Aboouf; Franco Guscetti; Nadine von Büren; Julia Armbruster; Hyrije Ademi; Maja Ruetten; Florinda Meléndez-Rodríguez; Thomas Rülicke; Alexander Seymer; Robert A Jacobs; Edith M Schneider Gasser; Julian Aragones; Drorit Neumann; Max Gassmann; Markus Thiersch
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.